Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials. (2019)

First Author: Andersen KM
Attributed to:  MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3899/jrheum.181123

PubMed Identifier: 30647191

Publication URI: http://europepmc.org/abstract/MED/30647191

Type: Journal Article/Review

Volume: 46

Parent Publication: The Journal of rheumatology

Issue: 8

ISSN: 0315-162X